Clinical Trial Update: A Phase IV Clinical Trial to Compare the Efficacy and Safety of Metformin+Sodium-Glucose Cotransporter 2 Inhibitor(SGLT2-i)+Thiazolidinedione (TZD) in Patients With Type 2 Diabetes [Phase 4]

View source ↗

Summary

A Phase IV clinical trial is recruiting to compare the efficacy and safety of metformin plus an SGLT2 inhibitor and a thiazolidinedione in adults with type 2 di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• SGLT2 inhibitor
• Thiazolidinedione (thiazolidinedione)
• metformin (metformin)

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Type 2 Diabetes | Phase 4 | Status: RECRUITING